ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS
Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Europäisches Patentamt - (2020) vom: 15. Okt. Zur Gesamtaufnahme - year:2020 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HYBERTSON BROOKS M [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2020-10-15, Last update posted on www.tib.eu: 2023-07-02, Last updated: 2023-07-08 |
|---|
| Patentnummer: |
US2020323982 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA00495212X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA00495212X | ||
| 003 | DE-627 | ||
| 005 | 20230708160909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210529s2020 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA00495212X | ||
| 035 | |a (EPA)US2020323982 | ||
| 035 | |a (EPA)60157652 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HYBERTSON BROOKS M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ELECTROCHEMICAL PLASMA ACTIVATED AQUEOUS CHEMOTHERAPEUTICS |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2020-10-15, Last update posted on www.tib.eu: 2023-07-02, Last updated: 2023-07-08 | ||
| 520 | |a Methods for the generation of electrochemical plasma activated aqueous chemotherapeutics (EPAAC) solutions are described. These solutions have been found to selectively reduce the proliferation of human pancreatic cancer cells, with no toxic effects for healthy cells. | ||
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a JOSLIN JESSICA M |4 aut | |
| 700 | 0 | |a BZDEK JUSTIN P |4 aut | |
| 700 | 0 | |a JOHNSON DEREK C |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2020) vom: 15. Okt. |
| 773 | 1 | 8 | |g year:2020 |g day:15 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/60157652/publication/US2020323982A1?q=US2020323982 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2020 |b 15 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2020 |b 15 |c 10 | ||